Thursday, 02 April 2020

China News

  • Mindray and HealthTrust renew agreement

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 May, 2012

    Singapore: The HealthTrust Purchasing Group is renewing its agreement for the entire range of physiological patient monitoring equipments with China-based Mindray Medical. According to thi...Read more

  • Bayer to acquire China's OTC firm

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2014

    Singapore: Bayer plans to acquire 100 percent of the shares of Dihon Pharmaceutical, a privately held pharmaceutical company specializing primarily in over-the-counter (OTC) and herbal trad...Read more

  • Sihuan gets SFDA nod for Nalmefene HCl

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: Sihuan Pharmaceutical's new category 3.1 drug, Nalmefene Hydrochloride Injection (Nalmefene Hydrochloride), received a new drug certificate (H20120078) and approval for producti...Read more

  • Consortium to sequence pediatric brain tumors

    China |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jan, 2013

    Singapore: The Children's Hospital of Philadelphia (CHOP), US, and BGI-Shenzhen, China, announced a formal agreement to collaborate on research into next generation sequencing and analysis...Read more

  • Start-ups redefining the industry

    China |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2012

    Life sciences industry in the Asia Pacific recorded the double digit growth of 16.6 percent, reaching $128.26 billion in 2010. Of this, pharma made up the major chunk of the revenue with 92...Read more

  • MicuRx next gen antibiotic gets US patent

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2012

    Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, has received a composition of matter patent covering its clinical candi...Read more

  • Scientists in China develop TB-HIV vaccine

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2012

    Singapore: Chinese scientists have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb). The research team, which was led by Dr Sidong Xiong of Fudan Univers...Read more

  • ShangPharma announces receipt of 'going private'

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: ShangPharma highlighted that its board of directors received a non-binding proposal letter dated July 6, 2012, from its chairman and CEO, Mr Michael Xin Hui, and entities affilia...Read more

  • China medtech firm gets ISO and CE for PET systems

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2012

    Singapore: Neusoft Positron Medical Systems, which is a joint venture between Neusoft Medical Systems and Positron Corporation for the development and manufacturing of positron emission tom...Read more

  • Shanghai Fosun buys 50% stake in Guangzhou Nanyang Tumour Hospital

    China |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2013

    Singapore: Shanghai Fosun Pharmaceutical has purchased a 50 percent stake in Guangzhou Nanyang Tumour Hospital. Fosun Pharma is on the spree of developing medical services and has purchase...Read more

  • GC-Rise attracts investors at China conference

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2013

    Singapore: GC-Rise Pharmaceutical attracted the attention of investors at the annual China Healthcare Investment Conference in Shanghai. Beijing-headquartered GC-Rise, which focuses on wome...Read more

  • Sinovac makes progress in EV71 clinical trial

    China |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jun, 2012

    Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, is conducting double-blinded, randomized, placebo controlled Phase III trial for its proprietary inact...Read more

  • Triple -ve breast cancer study gives +ve results

    China |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

    Singapore: EntreMed, a clinical-stage pharmaceutical company developing targeted therapeutics for the treatment of cancer in China and the US, published positive results of its preclinical ...Read more

  • M&A activity slows down in APAC

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    In 2011, the number of mergers and acquisitions in the life sciences field of Asia Pacific witnessed a fall. An independent M&A intelligence service mergermarket noted that the number ...Read more

  • BGI gets CFIUS nod to acquire Complete Genomics

    China |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2012

    Singapore: BGI-Shenzhen (BGI) and Complete Genomics have obtained clearance from the Committee on Foreign Investment in the US (CFIUS) regarding BGI's proposed acquisition of Complete. The...Read more

  • Mystic gets Japan, China patent nod for containers

    China |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

    Singapore: Mystic Pharmaceuticals, US, received key notices of allowance from Asian patent offices in the company's ongoing initiative to secure worldwide control over its novel designs. ...Read more

  • Stem cell industry has substantial growth potential

    China |  Analysis | By Piyusha Chatterjee | 0 Comment | 31 Jan, 2013

    The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promising field of biotechnology. Sir John Gurdon and Dr Shinya Yamanaka sha...Read more

  • Deyu subsidiary joins China Food Industry Association

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: The wholly-owned subsidiary of Deyu Agriculture, Detian Yu Biotechnology, Beijing, was elected a member of the China Food Industry Association. Deyu Agriculture is a vertically i...Read more